Pilot study assessing the direct medical cost of treating patients with cancer in Kenya; findings and implications for the future
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Pilot study assessing the direct medical cost of treating patients with cancer in Kenya; findings and implications for the future
Authors
Keywords
-
Journal
JOURNAL OF MEDICAL ECONOMICS
Volume -, Issue -, Pages 1-10
Publisher
Informa UK Limited
Online
2018-06-02
DOI
10.1080/13696998.2018.1484372
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Raising the Dose and Raising the Cost: The Case of Pembrolizumab in Lung Cancer
- (2017) Peter B Bach et al. JNCI-Journal of the National Cancer Institute
- A global comparison of the cost of patented cancer drugs in relation to global differences in wealth
- (2017) Daniel A. Goldstein et al. Oncotarget
- Availability of evidence of benefits on overall survival and quality of life of cancer drugs approved by European Medicines Agency: retrospective cohort study of drug approvals 2009-13
- (2017) Courtney Davis et al. BMJ-British Medical Journal
- Availability of evidence of benefits on overall survival and quality of life of cancer drugs approved by European Medicines Agency: retrospective cohort study of drug approvals 2009-13
- (2017) Courtney Davis et al. BMJ-British Medical Journal
- Raising the Dose and Raising the Cost: The Case of Pembrolizumab in Lung Cancer
- (2017) Peter B Bach et al. JNCI-Journal of the National Cancer Institute
- Prescription patterns and adequacy of blood pressure control among adult hypertensive patients in Kenya; findings and implications
- (2017) Jennifer M. Mbui et al. Expert Review of Clinical Pharmacology
- Economic analysis of the Nairobi Cancer Registry: Implications for expanding and enhancing cancer registration in Kenya
- (2016) Anne Korir et al. Cancer Epidemiology
- Cancer risks in Nairobi (2000-2014) by ethnic group
- (2016) Anne Korir et al. INTERNATIONAL JOURNAL OF CANCER
- Generic oncology drugs: are they all safe?
- (2016) Y Tony Yang et al. LANCET ONCOLOGY
- Target prices for mass production of tyrosine kinase inhibitors for global cancer treatment
- (2016) Andrew Hill et al. BMJ Open
- Global cancer statistics, 2012
- (2015) Lindsey A. Torre et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Incidence of cancer in Nairobi, Kenya (2004-2008)
- (2015) Anne Korir et al. INTERNATIONAL JOURNAL OF CANCER
- Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012
- (2014) Jacques Ferlay et al. INTERNATIONAL JOURNAL OF CANCER
- Delivering maximum clinical benefit at an affordable price: engaging stakeholders in cancer care
- (2014) Ronan J Kelly et al. LANCET ONCOLOGY
- Evidence-informed frameworks for cost-effective cancer care and prevention in low, middle, and high-income countries
- (2014) Kalipso Chalkidou et al. LANCET ONCOLOGY
- Variation in charges for 10 common blood tests in California hospitals: a cross-sectional analysis
- (2014) R. Y. Hsia et al. BMJ Open
- Full Disclosure — Out-of-Pocket Costs as Side Effects
- (2013) Peter A. Ubel et al. NEW ENGLAND JOURNAL OF MEDICINE
- Global burden of cancers attributable to infections in 2008: a review and synthetic analysis
- (2012) Catherine de Martel et al. LANCET ONCOLOGY
- Medicine prices, availability, and affordability in 36 developing and middle-income countries: a secondary analysis
- (2008) A Cameron et al. LANCET
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started